Richard Aranda insider trades: Gossamer Bio (GOSS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | GOSS | ↓ Sell | 1,908 | $0.66 | $1K | Direct | Jun 25, 2024 (1d) |
| Mar 18, 2024 | GOSS | ↓ Sell | 4,018 | $1.33 | $5K | Direct | Mar 19, 2024 (1d) |
| Jun 22, 2023 | GOSS | ↓ Sell | 1,814 | $1.29 | $2K | Direct | Jun 26, 2023 (4d) |
| Mar 16, 2023 | GOSS | ↓ Sell | 7,563 | $1.10 | $8K | Direct | Mar 20, 2023 (4d) |
| Oct 24, 2022 | GOSS | ↓ Sell | 4,757 | $12.07 | $57K | Direct | Oct 25, 2022 (1d) |
| Jun 22, 2022 | GOSS | ↓ Sell | 1,778 | $6.88 | $12K | Direct | Jun 23, 2022 (1d) |
| Mar 16, 2022 | GOSS | ↓ Sell | 6,278 | $8.28 | $52K | Direct | Mar 17, 2022 (1d) |
| Oct 25, 2021 | GOSS | ↓ Sell | 2,377 | $12.25 | $29K | Direct | Oct 26, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Richard Aranda's insider trades
Richard Aranda is Chief Medical Officer at Gossamer Bio (GOSS). Since Oct 25, 2021, Richard has reported no open-market purchases and 8 sales worth $168K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GOSS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.